| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Sunday, July 22, 2018 11:46:13 AM
Thank you beartrap. There are many great voices on the board, as you've pointed out in another post as well. Many bees doing their bit on the due diligence to enrich the hive intelligence that manifests, over time, but has to be heard over deliberate noise and false controversies intended to divert and distract and confound.
Yes, they get loudest when they think there might be progress ahead, that has not yet manifested and they get loud even sometimes, after an initial pause, after good news, even seemingly undisputable good news.
Obviously none of us know this will succeed. We've put our money where our mouths are and have done our best to do the due diligence to make a reasonable determination on the potential for success and then there is always going to be substantial risk in this field and with these tiny biotechs. Even the doctors don't always know, even when they are very excited about and seem to be confident about a treatment. It's all in the broader picture that is revealed, sometimes revealed on a flawed basis, sometimes not.
I think we're all mature enough to hash those things out without the help of the interlopers. But the best we can do is keep on thrashing through the details to ensure we've made the right decision to invest and then to continue being the busy bees that we are in sharing what we find and think.
Good luck to you and GLTA!
Yes, they get loudest when they think there might be progress ahead, that has not yet manifested and they get loud even sometimes, after an initial pause, after good news, even seemingly undisputable good news.
Obviously none of us know this will succeed. We've put our money where our mouths are and have done our best to do the due diligence to make a reasonable determination on the potential for success and then there is always going to be substantial risk in this field and with these tiny biotechs. Even the doctors don't always know, even when they are very excited about and seem to be confident about a treatment. It's all in the broader picture that is revealed, sometimes revealed on a flawed basis, sometimes not.
I think we're all mature enough to hash those things out without the help of the interlopers. But the best we can do is keep on thrashing through the details to ensure we've made the right decision to invest and then to continue being the busy bees that we are in sharing what we find and think.
Good luck to you and GLTA!
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
